Taigen Biopharmaceutica (Taiwan) Today
| 4157 Stock | TWD 12.60 0.05 0.40% |
Performance0 of 100
| Odds Of DistressOver 65
|
Taigen Biopharmaceutica is selling for under 12.60 as of the 22nd of November 2024; that is 0.40 percent increase since the beginning of the trading day. The stock's lowest day price was 12.35. Taigen Biopharmaceutica has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Taigen Biopharmaceuticals Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of November 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Moving together with Taigen Stock
| 0.64 | 1516 | Falcon Power Split | PairCorr |
| 0.7 | 6785 | Alar Pharmaceuticals | PairCorr |
| 0.7 | 1435 | Chung Fu Tex | PairCorr |
| 0.76 | 1423 | Reward Wool Industry | PairCorr |
| 0.85 | 3465 | New Advanced Electronics | PairCorr |
Moving against Taigen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Taigen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Taigen Biopharmaceutica's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Taigen Biopharmaceutica or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Taigen Biopharmaceuticals Holdings (4157) is traded on Taiwan OTC Exchange in Taiwan and employs 23 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 11.33 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Taigen Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Taigen Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Taigen Biopharmaceutica operates under Biotechnology sector and is part of Health Care industry. The entity has 716.84 M outstanding shares.
Taigen Biopharmaceutica generates positive cash flow from operations, but has no cash available
Check Taigen Biopharmaceutica Probability Of Bankruptcy
Ownership AllocationTaigen Biopharmaceutica shows a total of 716.84 Million outstanding shares. Taigen Biopharmaceutica maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Taigen Ownership Details
Taigen Biopharmaceutica Risk Profiles
Although Taigen Biopharmaceutica's alpha and beta are two of the key measurements used to evaluate Taigen Biopharmaceutica's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.04 | |||
| Standard Deviation | 1.52 | |||
| Variance | 2.3 | |||
| Risk Adjusted Performance | (0.11) |
Taigen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Taigen Biopharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Taigen Biopharmaceutica Corporate Management
Elected by the shareholders, the Taigen Biopharmaceutica's board of directors comprises two types of representatives: Taigen Biopharmaceutica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taigen. The board's role is to monitor Taigen Biopharmaceutica's management team and ensure that shareholders' interests are well served. Taigen Biopharmaceutica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taigen Biopharmaceutica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| ChiHsin King | VP Research | Profile | |
| MingChu Hsu | Founder Director | Profile | |
| KuoLung Huang | CEO, Chairman | Profile | |
| Richard Lu | VP Fin | Profile |
Additional Tools for Taigen Stock Analysis
When running Taigen Biopharmaceutica's price analysis, check to measure Taigen Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taigen Biopharmaceutica is operating at the current time. Most of Taigen Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Taigen Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taigen Biopharmaceutica's price. Additionally, you may evaluate how the addition of Taigen Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.